Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death

European Journal of Immunology

Volumn 37, Issue 3, 2007, Pages 663-674

  Chen, Gang ^a   Tai, Albert K ^a   Lin, Miao ^a   Chang, Francesca ^a   Terhorst, Cox ^b   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; CD8 T cells; Knockout mice

Indexed keywords

CASPASE 9; CD8 ANTIGEN; MESSENGER RNA; OVALBUMIN; PROTEIN P73; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; T LYMPHOCYTE RECEPTOR; SH2D1A PROTEIN, MOUSE; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; FEMALE; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MITOCHONDRION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN INDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT;

ANIMALS; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 34147192525     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636417     Document Type: Article

References (56)

1. Purtilo, D. T., Sakamoto, K., Barnabei, V., Seeley, J., Bechtold, T., Rogers, G., Yetz, J. and Harada, S., Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): Update on studies of the registry. Am. J. Med. 1982. 73: 49-56.
2. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S. et al., The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998. 395: 462-469.
3. Coffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P. et al., Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 1998. 20: 129-135.
4. Wu, C., Sayos, J., Wang, N., Howie, D., Coyle, A. and Terhorst, C., Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease. Immunogenetics 2000. 51: 805-815.
5. Veillette, A., SLAM family receptors regulate immunity with and without SAP-related adaptors. J. Exp. Med. 2004. 199: 1175-1178.
6. Veillette, A., Immune regulation by SLAM family receptors and SAP-related adaptors. Nat. Rev. Immunol. 2006. 6: 56-66.
7. Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E. et al., NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 2001. 194: 235-246.
8. Boles, K. S. and Mathew, P. A., Molecular cloning of CS1, a novel human natural killer cell receptor belonging to the CD2 subset of the immunoglobulin superfamily. Immunogenetics 2001. 52: 302-307.
9. Chan, B., Lanyi, A., Song, H. K., Griesbach, J., Simarro-Grande, M., Poy, F., Howie, D. et al., SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 2003. 5: 155-160.
10. Aoukaty, A. and Tan, R., Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphomositide 3-kinase. J. Biol. Chem. 2002. 277: 13331-13337.
11. Engel, P., Eck, M. J. and Terhorst, C., The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat. Rev. Immunol. 2003. 3: 813-821.
12. Morra, M., Barrington, R. A., Abadia-Molina, A. C., Okamoto, S., Julien, A., Gullo, C., Kalsy, A. et al., Defective B cell responses in the absence of SH2D1A. Proc. Natl. Acad. Sci. USA 2005. 102: 4819-4823.
13. Nichols, K. E., Ma, C. S., Cannons, J. L., Schwartzberg, P. L. and Tangye, S. G., Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 2005. 203: 180-199.
14. Pasquier, B., Yin, L., Fondaneche, M. C., Relouzat, F., Bloch-Queyrat, C., Lambert, N., Fischer, A. et al., Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 2005. 201: 695-701.
15. Wu, C., Nguyen, K. B., Pien, G. C., Wang, N., Gullo, C., Howie, D., Sosa, M. R. et al., SAP controls T cell responses to virus and terminal differentiation of Th2 cells. Nat. Immunol. 2001. 2: 410-414.
16. Cannons, J. L., Yu, L. J., Hill, B., Mijares, L. A., Dombroski, D., Nichols, K. E., Antonellis, A. L. et al., SAP regulates T(H 2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity 2004. 21: 693-706.
17. Ma, C. S., Hare, N. J., Nichols, K. E., Dupre, L., Andolfi, G., Roncarolo, M. G., Adelstein, S. et al., Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4(+) T cells. J. Clin. Invest. 2005. 115: 1049-1059.
18. Al-Alem, U., Li, C., Forey, N., Relouzat, F., Fondaneche, M. C., Tavtigian, S. V., Wang, Z. Q. et al., Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap. Blood 2005. 106: 2069-2075.
19. Chen, G., Tai, A. K., Lin, M., Chang, F., Terhorst, C. and Huber, B. T., Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J. Immunol. 2005. 175: 2212-2218.
20. Czar, M. J., Kersh, E. N., Mijares, L. A., Lanier, G., Lewis, J., Yap, G., Chen, A. et al., Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc, Nat. Acad. Sci. USA 2001. 98: 7449-7454.
21. Cohen, P. L. and Eisenberg, R. A., Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991. 9: 243-269.
22. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J. et al., Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
23. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
24. Brunner, T., Wasem, C., Torgler, R., Cima, L, Jakob, S. and Corazza, N., Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Semin. Immunol. 2003. 15: 167-176.
25. Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G. and Dowdy, S. F., A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 2000. 407: 642-645.
26. Field, S. J., Tsai, F. Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Jr., Livingston, D. M., Orkin, S. H. and Greenberg, M. E., E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996. 85: 549-561.
27. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E. and Dyson, N. J., Tumor induction and tissue atrophy in mice lacking E217-1. Cell 1996. 85: 537-548.
28. Teixeiro, E., Daniels, M. A., Hausmann, B., Schrum, A. G., Naeher, D., Luescher, I., Thome, M. et al., T cell division and death are segregated by mutation of TCRbeta chain constant domains. Immunity 2004. 21: 515-526.
29. Irwin, M. S. and Kaelin, W. G., p53 family update: P73 and p63 develop their own identities. Cell Growth Differ. 2001. 12: 337-349.
30. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A. et al., Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997. 90: 809-819.
31. Casciano, L, Ponzoni, M., Lo Cunsolo, C., Tonini, G. P. and Romani, M., Different p73 splicing variants are expressed in distinct turnout areas of a multifocal neuroblastoma. Cell Death Differ. 1999. 6: 391-393.
32. Lo Cunsolo, C., Casciano, I., Banelli, B., Tonini, G. P. and Romani, M., Refined chromosomal localization of the putative tumor suppressor gene TP73. Cytogenet. Cell. Genet. 1998. 82: 199-201.
33. De Laurenzi, V. D., Catani, M. V., Terrinoni, A., Corazzari, M., Melino, G., Costanzo, A., Levrero, M. and Knight, R. A., Additional complexity in p73: Induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. Cell Death Differ. 1999. 6: 389-390.
34. De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. and Melino, G., Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med. 1998. 188: 1763-1768.
35. Grob, T. J., Novak, U., Maisse, C., Barcaroli, D., Luthi, A. U., Pirnia, F., Hugh, B. et al., Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ. 2001. 8: 1213-1223.
36. Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R. et al., Role for the p53 homologue p73 in E217-1-induced apoptosis. Nature 2000. 407: 645-648.
37. Gupta, S., Bi, R. and Gollapudi, S., Central memory and effector memory subsets of human CD4(+) and CD8(+) Tcells display differential sensitivity to TNF- {alpha}-induced apoptosis. Ann. N. Y. Acad. Sci. 2005. 1050: 108-114.
38. + T cells to apoptosis in vivo. J. Immunol. 2002. 169: 3760-3770.
39. Kaech, S. M., Hemby, S., Kersh, E. and Ahmed, R., Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002. 111: 837-851.
40. Ramadan, S., Terrinoni, A., Catani, M. V., Sayan, A. E., Knight, R. A., Mueller, M., Krammer, P. H. et al., p73 induces apoptosis by different mechanisms. Biochem. Biophys. Res. Commun. 2005. 331: 713-717.
41. Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F. and Jacks, T., p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002. 416: 560-564.
42. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. R., T cell receptor antagonist peptides induce positive selection. Cell 1994. 76: 17-27.
43. Atkinson, E. A., Ostergaard, H., Kane, K., Pinkoski, M. J., Caputo, A., Olszowy, M. W. and Bleackley, R. C., A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT. J. Biol. Chem. 1996. 271: 5968-5971.
44. + T cell responses through regulated FasL expression. Immunity 2005. 23: 649-659.
45. Yang, C., Zhou, W., Jeon, M. S., Demydenko, D., Harada, Y., Zhou, H. and Liu, Y. C., Negative regulation of the E3 ubiquitin ligase Itch via Fyn-mediated tyrosine phosphorylation. Mol. Cell 2006. 21: 135-141.
46. Rossi, M., De Laurenzi, V., Munarriz, E., Green, D. R., Liu, Y. C., Vousden, K. H., Cesareni, G. and Melino, G., The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J. 2005. 24: 836-848.
47. Fang, D., Elly, C., Gao, B., Fang, N., Altman, Y., Joazeiro, C., Hunter, T. et al., Dysregulation of T lymphocyte function in itchy mice: A role for Itch in Th2 differentiation. Nat. Immunol. 2002. 3: 281-287.
48. Senoo, M., Manis, J. P., Alt, F. W. and McKeon, F., p63 and p73 are not required for the development and p53-dependent apoptosis of T cells. Cancer Cell 2004. 6: 85-89.
49. Flores, E. R., Sengupta, S., Miller, J. B., Newman, J. J., Bronson, R., Crowley, D., Yang, A. et al., Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005. 7: 363-373.
50. Hakem, R., Hakem, A., Duncan, G. S., Henderson, J. T., Woo, M., Soengas, M. S., Elia, A. et al., Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998. 94: 339-352.
51. Kuida, K., Haydar, T. F., Kuan, C. Y., Gu, Y., Taya, C., Karasuyama, H., Su, M. S. et al., Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998. 94: 325-337.
52. Latinis, K. M., Norian, L. A., Eliason, S. L. and Koretzky, G. A., Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 1997. 272: 31427-31434.
53. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A. and Green, D. R., DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol. Cell 1998. 1: 543-551.
54. Mittelstadt, P. R. and Ashwell, J. D., Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells. J. Biol. Chem. 1999. 274: 3222-3227.
55. Genestier, L., Kasibhatla, S., Brunner, T. and Green, D. R., Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J. Exp. Med. 1999. 189: 231-239.
56. Chau, B. N., Chen, T. T., Wan, Y. Y., DeGregori, J. and Wang, J. Y., Tumor necrosis factor alpha-induced apoptosis requires p73 and c-Ab1 activation downstream of Rb degradation. Mol. Cell. Biol. 2004. 24: 4438-4447.